Huang, Yen-HsiangYen-HsiangHuangHung, Jen-YuJen-YuHungKo, How-WenHow-WenKoSu, Po-LanPo-LanSuLai, Chun-LiangChun-LiangLaiChang, Huang-ChihHuang-ChihChangHsia, Te-ChunTe-ChunHsiaLin, Sheng-HaoSheng-HaoLinWu, Kuan-LiKuan-LiWuYang, Cheng-TaCheng-TaYangSu, Wu-ChouWu-ChouSuChu, Yi-ChunYi-ChunChuWang, Chin-ChouChin-ChouWangWEI-YU LIAOYEN-TING LINLin, Ching-HsiungChing-HsiungLinLin, Meng-ChihMeng-ChihLinHsu, Kuo-HsuanKuo-HsuanHsuTseng, Jeng-SenJeng-SenTsengYang, Tsung-YingTsung-YingYangChen, Kun-ChiehKun-ChiehChenLee, Mei-HsuanMei-HsuanLeeSUNG-LIANG YUCHAO-CHI HOChang, Gee-ChenGee-ChenChang2021-07-302021-07-3020211758-8340https://scholars.lib.ntu.edu.tw/handle/123456789/575432The relative importance of predictive factors for advanced non-small cell lung cancer (NSCLC) patients on epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI) treatment remains unclear.enepidermal growth factor receptor; local treatment; more than five years; non-small cell lung cancer; scoring model; tyrosine kinase inhibitor[SDGs]SDG3epidermal growth factor receptor; erlotinib; gefitinib; protein tyrosine kinase inhibitor; accuracy; adrenal metastasis; adult; advanced cancer; aged; allele; amino acid sequence; area under the curve; Article; biopsy; bone metastasis; brain metastasis; cancer patient; cancer radiotherapy; cancer recurrence; cancer research; cancer staging; cancer surgery; chemoradiotherapy; chronic patient; cohort analysis; computer assisted tomography; confidence interval; controlled study; diagnostic test accuracy study; disease exacerbation; DNA sequence; ECOG Performance Status; exon; female; follow up; gene mutation; genetic screening; heterozygote; human; human cell; human tissue; liquid biopsy; liver metastasis; local therapy; lung cancer; lung lesion; major clinical study; male; mass spectrometry; medical history; multicenter study; non small cell lung cancer; plasma cell; postoperative complication; prediction; predictive value; prevalence; primary tumor; receiver operating characteristic; retrospective study; risk factor; scoring system; sensitivity and specificity; small cell lung cancer; smoking; stomach cancer; system analysisThe relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 studyjournal article10.1177/17588359211018022340937432-s2.0-85106656727https://scholars.lib.ntu.edu.tw/handle/123456789/571107